OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Parkinson's disease
Lorraine V. Kalia, Anthony E. Lang
The Lancet (2015) Vol. 386, Iss. 9996, pp. 896-912
Closed Access | Times Cited: 4810

Showing 1-25 of 4810 citing articles:

Parkinson disease
Werner Poewe, Klaus Seppi, Caroline M. Tanner, et al.
Nature Reviews Disease Primers (2017) Vol. 3, Iss. 1
Closed Access | Times Cited: 3800

Ageing as a risk factor for neurodegenerative disease
Yujun Hou, Xiuli Dan, Mansi Babbar, et al.
Nature Reviews Neurology (2019) Vol. 15, Iss. 10, pp. 565-581
Closed Access | Times Cited: 2374

Parkinson's disease
Bastiaan R. Bloem, Michael S. Okun, Christine Klein
The Lancet (2021) Vol. 397, Iss. 10291, pp. 2284-2303
Open Access | Times Cited: 2162

Epidemiology of Parkinson’s disease
Ole‐Bjørn Tysnes, Anette Storstein
Journal of Neural Transmission (2017) Vol. 124, Iss. 8, pp. 901-905
Closed Access | Times Cited: 2044

Mitophagy and Quality Control Mechanisms in Mitochondrial Maintenance
Sarah Pickles, Pierre Vigié, Richard J. Youle
Current Biology (2018) Vol. 28, Iss. 4, pp. R170-R185
Open Access | Times Cited: 1608

The epidemiology of Parkinson's disease: risk factors and prevention
Alberto Ascherio, Michael A. Schwarzschild
The Lancet Neurology (2016) Vol. 15, Iss. 12, pp. 1257-1272
Closed Access | Times Cited: 1547

Challenges in the diagnosis of Parkinson's disease
Eduardo Tolosa, Alícia Garrido, Sonja W. Scholz, et al.
The Lancet Neurology (2021) Vol. 20, Iss. 5, pp. 385-397
Open Access | Times Cited: 1014

Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States
Mark P. Mattson, Thiruma V. Arumugam
Cell Metabolism (2018) Vol. 27, Iss. 6, pp. 1176-1199
Open Access | Times Cited: 932

The genetic architecture of Parkinson's disease
Cornelis Blauwendraat, Mike A. Nalls, Andrew Singleton
The Lancet Neurology (2019) Vol. 19, Iss. 2, pp. 170-178
Open Access | Times Cited: 874

Dopamine: Functions, Signaling, and Association with Neurological Diseases
Marianne Klein, Daniella S. Battagello, Ariel R. Cardoso, et al.
Cellular and Molecular Neurobiology (2018) Vol. 39, Iss. 1, pp. 31-59
Closed Access | Times Cited: 802

α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies
Yvette C. Wong, Dimitri Krainc
Nature Medicine (2017) Vol. 23, Iss. 2, pp. 1-13
Open Access | Times Cited: 733

Biomarkers for neurodegenerative diseases
Oskar Hansson
Nature Medicine (2021) Vol. 27, Iss. 6, pp. 954-963
Open Access | Times Cited: 728

Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease
Lena F. Burbulla, Pingping Song, Joseph R. Mazzulli, et al.
Science (2017) Vol. 357, Iss. 6357, pp. 1255-1261
Open Access | Times Cited: 724

α-Synuclein binds to TOM20 and inhibits mitochondrial protein import in Parkinson’s disease
Roberto Di Maio, Paul J. Barrett, Eric K. Hoffman, et al.
Science Translational Medicine (2016) Vol. 8, Iss. 342
Open Access | Times Cited: 524

The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders
Katarzyna Socała, Urszula Doboszewska, Aleksandra Szopa, et al.
Pharmacological Research (2021) Vol. 172, pp. 105840-105840
Open Access | Times Cited: 496

Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade
Masha G. Savelieff, Geewoo Nam, Juhye Kang, et al.
Chemical Reviews (2018) Vol. 119, Iss. 2, pp. 1221-1322
Closed Access | Times Cited: 482

Parkinson's disease: Mechanisms, translational models and management strategies
Chand Raza, Rabia Anjum, Noor ul Ain Shakeel
Life Sciences (2019) Vol. 226, pp. 77-90
Closed Access | Times Cited: 481

Defects in trafficking bridge Parkinson's disease pathology and genetics
Asa Abeliovich, Aaron D. Gitler
Nature (2016) Vol. 539, Iss. 7628, pp. 207-216
Closed Access | Times Cited: 425

Effect of High-Intensity Treadmill Exercise on Motor Symptoms in Patients With De Novo Parkinson Disease
Margaret Schenkman, Charity G. Moore, Wendy M. Kohrt, et al.
JAMA Neurology (2017) Vol. 75, Iss. 2, pp. 219-219
Open Access | Times Cited: 398

Excessive burden of lysosomal storage disorder gene variants in Parkinson’s disease
Laurie Robak, Iris E. Jansen, Jeroen van Rooij, et al.
Brain (2017) Vol. 140, Iss. 12, pp. 3191-3203
Open Access | Times Cited: 392

Exercise as a prescription for patients with various diseases
Xin Luan, Xiangyang Tian, Haixin Zhang, et al.
Journal of sport and health science/Journal of Sport and Health Science (2019) Vol. 8, Iss. 5, pp. 422-441
Open Access | Times Cited: 377

Influence of gut microbiota on neuropsychiatric disorders
María Carmen Cénit, Yolanda Sanz, Pilar Codoñer‐Franch
World Journal of Gastroenterology (2017) Vol. 23, Iss. 30, pp. 5486-5486
Open Access | Times Cited: 371

Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson’s disease
Chin‐Hsien Lin, Chieh‐Chang Chen, Han‐Lin Chiang, et al.
Journal of Neuroinflammation (2019) Vol. 16, Iss. 1
Open Access | Times Cited: 367

Role of Cardiolipin in Mitochondrial Function and Dynamics in Health and Disease: Molecular and Pharmacological Aspects
Giuseppe Paradies, Valeria Paradies, Francesca Ruggiero, et al.
Cells (2019) Vol. 8, Iss. 7, pp. 728-728
Open Access | Times Cited: 363

Page 1 - Next Page

Scroll to top